These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 79936)

  • 1. Thaw-siphon technique for factor-VIII cryoprecipitate.
    Foster P; White B
    Lancet; 1978 Sep; 2(8089):574. PubMed ID: 79936
    [No Abstract]   [Full Text] [Related]  

  • 2. Thaw-siphon technique for factor VIII cryoprecipitate.
    Mason EC
    Lancet; 1978 Sep; 2(8090):636-7. PubMed ID: 80566
    [No Abstract]   [Full Text] [Related]  

  • 3. An improved thaw-siphon method for the cryoprecipitate preparation.
    Kang EP
    Vox Sang; 1980; 38(3):172-7. PubMed ID: 6770544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thaw-siphon technique for production of cryoprecipitate concentrate of factor VIII.
    Mason EC
    Lancet; 1978 Jul; 2(8079):15-7. PubMed ID: 78212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryoprecipitate of intermediate purity produced in a closed thaw-siphon system from DDAVP stimulated blood donor plasma.
    Konecka G; Bykowska K; Ludwicka A; Letowska M; Wegrzynowicz Z; Sablinski J; Lopaciuk S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):565-70. PubMed ID: 1714861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
    Mason EC; Pepper DS; Griffin B
    Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
    Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
    Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of a cryoprecipitate by the thaw and siphon method].
    Daszyński J; Rosiek A; Lopaciuk S
    Acta Haematol Pol; 1985; 16(3-4):139-43. PubMed ID: 3939069
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo characteristics of thaw siphon cryoprecipitate compared to other factor VIII preparations.
    Toolis F; McKay G; Prowse CV
    Thromb Haemost; 1980 Feb; 43(1):25-7. PubMed ID: 6773169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of large-scale fractionation methods. VI. An improved method for preparation of antihemophilic factor.
    Wickerhauser M; Mercer JE; Eckenrode JW
    Vox Sang; 1978; 35(1-2):18-31. PubMed ID: 664566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow thaw siphon technique for cryoprecipitate production.
    Chudgar UH; Chandy M; Pulimood RB; Khanduri U
    Indian J Med Res; 1989 Aug; 90():295-9. PubMed ID: 2516011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of qucik and slow thaw methods of producing cryoprecipitate antihaemophilic factor from fresh and 24-hour-old blood.
    Bloom AL; Giddings JC; Bevan B; Letton M; Drummond RJ
    J Clin Pathol; 1969 Jul; 22(4):447-52. PubMed ID: 5798632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: Improved factor VIII yield in cryoprecipitate using a quick thaw technique.
    Davidson JF; McAdam JH; Mackenzie MJ; Kavanagh ML
    Thromb Diath Haemorrh; 1975 Nov; 34(2):590. PubMed ID: 1198502
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the 'Mason' (continuous-thaw-siphon) method for cryoprecipitate production.
    Prowse CV; McGill A
    Vox Sang; 1979; 37(4):235-43. PubMed ID: 386613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in cryoprecipitate production.
    Rock G; Tittley P
    Transfusion; 1977; 17(1):50-3. PubMed ID: 841673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thaw-siphon technique for factor-VIII cryoprecipitate.
    Das PC; Smit Sibinga CT
    Lancet; 1978 Jul; 2(8083):273. PubMed ID: 79076
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of heat treatment on FVIII:C recovery from freeze dried cryoprecipitate.
    Benny AG; Ockelford PA; Johns AS; Scott RH; Woodfield DG; Berry EW
    J Clin Pathol; 1988 Sep; 41(9):945-7. PubMed ID: 3142936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoption of new methods for high-yield factor VIII recovery.
    Rock G
    Transfusion; 1989 Jun; 29(5):466-7. PubMed ID: 2499960
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of a heat-treated factor VIII/von Willebrand factor concentrate prepared from heparinized plasma.
    Palmer DS; Ganz PR; Perkins H; Rosborough D; Rock G
    Thromb Haemost; 1990 Jun; 63(3):392-402. PubMed ID: 2119525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameters affecting the fractionation of FVIII:C activity in production of very high purity AHF concentrate.
    Törmä E; Myllylä G
    Scand J Haematol Suppl; 1984; 40():123-6. PubMed ID: 6433441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.